{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:42:31Z","timestamp":1787236951530,"version":"build-2736575974"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,29]]},"DOI":"10.7759\/cureus.95715","type":"journal-article","created":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T05:16:13Z","timestamp":1761801373000},"source":"Crossref","is-referenced-by-count":1,"title":["Low-Dose Colchicine in Patients With Type 2 Diabetes With Recent Myocardial Infarction in the Colchicine Cardiovascular Outcome Trial (COLCOT): A Systematic Review"],"prefix":"10.7759","author":[{"given":"Hurmah","family":"Shoaib","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Saeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Usama Hassan","family":"Nawaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wajeeh-ur-Rehman","family":"Kashif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muazzam","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabeen","family":"Irshad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcm.2020.10.007","article-title":"Colchicine for the treatment of coronary artery disease","volume":"31","author":"Aimo A","year":"2021","unstructured":"Aimo A, Pascual-Figal DA, Barison A, et al.. Colchicine for the treatment of coronary artery disease. Trends Cardiovasc Med. 2021, 31:497-504. 10.1016\/j.tcm.2020.10.007","journal-title":"Trends Cardiovasc Med"},{"key":"ref2","article-title":"Colchicine in atherosclerotic vascular disease: The good, the bad, and the ugly","volume":"24","author":"Tuvali O","year":"2022","unstructured":"Tuvali O, Sella G, Haberman D, Cuciuc V, George J. Colchicine in atherosclerotic vascular disease: The good, the bad, and the ugly. Isr Med Assoc J. 2022, 24:191-7.","journal-title":"Isr Med Assoc J"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1253\/circrep.CR-21-0065","article-title":"Low-dose colchicine in coronary artery disease\u3000- Systematic review and meta-analysis","volume":"3","author":"Abrantes AM","year":"2021","unstructured":"Abrantes AM, Nogueira-Garcia B, Alves M, Teixeira Passos D, Brito D, Pinto FJ, Caldeira D. Low-dose colchicine in coronary artery disease\u3000- Systematic review and meta-analysis. Circ Rep. 2021, 3:457-64. 10.1253\/circrep.CR-21-0065","journal-title":"Circ Rep"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.7326\/J24-0026","article-title":"In patients with type 2 diabetes and recent MI, colchicine reduced a composite CV outcome at 23 mo","volume":"177","author":"Bates ER","year":"2024","unstructured":"Bates ER. In patients with type 2 diabetes and recent MI, colchicine reduced a composite CV outcome at 23 mo. Ann Intern Med. 2024, 177:JC54. 10.7326\/J24-0026","journal-title":"Ann Intern Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/FJC.0000000000001672","article-title":"Colchicine in coronary artery disease: Where do we stand?","volume":"85","author":"Bonaventura A","year":"2025","unstructured":"Bonaventura A, Potere N, Liberale L, Kraler S, Weber BN, Abbate A. Colchicine in coronary artery disease: Where do we stand?. J Cardiovasc Pharmacol. 2025, 85:243-7. 10.1097\/FJC.0000000000001672","journal-title":"J Cardiovasc Pharmacol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jfma.2024.11.014","article-title":"Colchicine to prevent cardiovascular death after an acute myocardial infarction","author":"Chang YC","year":"2024","unstructured":"Chang YC, Yeh LC, Lin TT, et al.. Colchicine to prevent cardiovascular death after an acute myocardial infarction. J Formos Med Assoc. 2024, 10.1016\/j.jfma.2024.11.014","journal-title":"J Formos Med Assoc"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/ehjqcco\/qcae021","article-title":"Cost-effectiveness of low-dose colchicine in patients with chronic coronary disease in The Netherlands","volume":"11","author":"Fiolet AT","year":"2025","unstructured":"Fiolet AT, Keusters W, Blokzijl J, et al.. Cost-effectiveness of low-dose colchicine in patients with chronic coronary disease in The Netherlands. Eur Heart J Qual Care Clin Outcomes. 2025, 11:89-96. 10.1093\/ehjqcco\/qcae021","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.740896","article-title":"A meta-analysis evaluating the colchicine therapy in patients with coronary artery disease","volume":"8","author":"Grajek S","year":"2021","unstructured":"Grajek S, Michalak M, Urbanowicz T, Olasi\u0144ska-Wi\u015bniewska A. A meta-analysis evaluating the colchicine therapy in patients with coronary artery disease. Front Cardiovasc Med. 2021, 8:740896. 10.3389\/fcvm.2021.740896","journal-title":"Front Cardiovasc Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2024.01.004","article-title":"The impact of colchicine on patients with acute and chronic coronary artery disease","volume":"125","author":"Madanchi M","year":"2024","unstructured":"Madanchi M, Young M, Tersalvi G, et al.. The impact of colchicine on patients with acute and chronic coronary artery disease. Eur J Intern Med. 2024, 125:1-9. 10.1016\/j.ejim.2024.01.004","journal-title":"Eur J Intern Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2023.05.055","article-title":"Low-dose colchicine for secondary prevention of coronary artery disease: JACC review topic of the week","volume":"82","author":"Nelson K","year":"2023","unstructured":"Nelson K, Fuster V, Ridker PM. Low-dose colchicine for secondary prevention of coronary artery disease: JACC review topic of the week. J Am Coll Cardiol. 2023, 82:648-60. 10.1016\/j.jacc.2023.05.055","journal-title":"J Am Coll Cardiol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2021.06.037","article-title":"Colchicine in patients with chronic coronary disease in relation to prior acute coronary syndrome","volume":"78","author":"Opstal TS","year":"2021","unstructured":"Opstal TS, Fiolet AT, van Broekhoven A, et al.. Colchicine in patients with chronic coronary disease in relation to prior acute coronary syndrome. J Am Coll Cardiol. 2021, 78:859-66. 10.1016\/j.jacc.2021.06.037","journal-title":"J Am Coll Cardiol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1177\/0003319720985644","article-title":"Colchicine use in acute coronary syndromes: An update","volume":"72","author":"Tapoi L","year":"2021","unstructured":"Tapoi L, Benchea L, Siriopol D, Kanbay M, Covic A. Colchicine use in acute coronary syndromes: An update. Angiology. 2021, 72:503-10. 10.1177\/0003319720985644","journal-title":"Angiology"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2022.06.009","article-title":"Efficacy of colchicine in the treatment of patients with coronary artery disease: A Mini-Review","volume":"44","author":"Yong J","year":"2022","unstructured":"Yong J, Tian J, Jiang W, Zhao X, Zhang H, Song X. Efficacy of colchicine in the treatment of patients with coronary artery disease: A Mini-Review. Clin Ther. 2022, 44:1150-9. 10.1016\/j.clinthera.2022.06.009","journal-title":"Clin Ther"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s11883-024-01267-7","article-title":"\"Anti-inflammatory Therapies in Atherosclerosis - Where are we going?\"","volume":"27","author":"Punnanithinont N","year":"2024","unstructured":"Punnanithinont N, Kambalapalli S, Iskander B, et al.. \"Anti-inflammatory Therapies in Atherosclerosis - Where are we going?\". Curr Atheroscler Rep. 2024, 27:19. 10.1007\/s11883-024-01267-7","journal-title":"Curr Atheroscler Rep"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-023-04341-9","article-title":"The low-dose colchicine in patients after non-CABG cardiac surgery: A randomized controlled trial","volume":"27","author":"Pan T","year":"2023","unstructured":"Pan T, Jiang CY, Zhang H, et al.. The low-dose colchicine in patients after non-CABG cardiac surgery: A randomized controlled trial. Crit Care. 2023, 27:49. 10.1186\/s13054-023-04341-9","journal-title":"Crit Care"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2021.02.003","article-title":"Updating guidance for reporting systematic reviews: Development of the PRISMA 2020 statement","volume":"134","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. Updating guidance for reporting systematic reviews: Development of the PRISMA 2020 statement. J Clin Epidemiol. 2021, 134:103-12. 10.1016\/j.jclinepi.2021.02.003","journal-title":"J Clin Epidemiol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.5195\/jmla.2020.739","article-title":"A comparison of patient, intervention, comparison, outcome (PICO) to a new, alternative clinical question framework for search skills, search results, and self-efficacy: A randomized controlled trial","volume":"108","author":"Kloda LA","year":"2020","unstructured":"Kloda LA, Boruff JT, Cavalcante AS. A comparison of patient, intervention, comparison, outcome (PICO) to a new, alternative clinical question framework for search skills, search results, and self-efficacy: A randomized controlled trial. J Med Libr Assoc. 2020, 108:185-94. 10.5195\/jmla.2020.739","journal-title":"J Med Libr Assoc"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-010606","article-title":"Conflicts of interest and spin in reviews of psychological therapies: A systematic review","volume":"6","author":"Lieb K","year":"2016","unstructured":"Lieb K, von der Osten-Sacken J, Stoffers-Winterling J, Reiss N, Barth J. Conflicts of interest and spin in reviews of psychological therapies: A systematic review. BMJ Open. 2016, 6:e010606. 10.1136\/bmjopen-2015-010606","journal-title":"BMJ Open"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2023.06.015","article-title":"Risk-of-bias assessment using Cochrane's revised tool for randomized trials (RoB 2) was useful but challenging and resource-intensive: Observations from a systematic review","volume":"161","author":"Crocker TF","year":"2023","unstructured":"Crocker TF, Lam N, Jord\u00e3o M, et al.. Risk-of-bias assessment using Cochrane's revised tool for randomized trials (RoB 2) was useful but challenging and resource-intensive: Observations from a systematic review. J Clin Epidemiol. 2023, 161:39-45. 10.1016\/j.jclinepi.2023.06.015","journal-title":"J Clin Epidemiol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/jrsm.1411","article-title":"Risk-of-bias VISualization (robvis): An R package and Shiny web app for visualizing risk-of-bias assessments","volume":"12","author":"McGuinness LA","year":"2021","unstructured":"McGuinness LA, Higgins JP. Risk-of-bias VISualization (robvis): An R package and Shiny web app for visualizing risk-of-bias assessments. Res Synth Methods. 2021, 12:55-61. 10.1002\/jrsm.1411","journal-title":"Res Synth Methods"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1002\/alr.20095","article-title":"Development of an evidence-based review with recommendations using an online iterative process","volume":"1","author":"Rudmik L","year":"2011","unstructured":"Rudmik L, Smith TL. Development of an evidence-based review with recommendations using an online iterative process. Int Forum Allergy Rhinol. 2011, 1:431-7. 10.1002\/alr.20095","journal-title":"Int Forum Allergy Rhinol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.2337\/dc23-1825","article-title":"Low-dose colchicine in patients with type 2 diabetes and recent myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)","volume":"47","author":"Roubille F","year":"2024","unstructured":"Roubille F, Bouabdallaoui N, Kouz S, et al.. Low-dose colchicine in patients with type 2 diabetes and recent myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT). Diabetes Care. 2024, 47:467-70. 10.2337\/dc23-1825","journal-title":"Diabetes Care"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1093\/ehjqcco\/qcaa045","article-title":"Cost-effectiveness of low-dose colchicine after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)","volume":"7","author":"Samuel M","year":"2021","unstructured":"Samuel M, Tardif JC, Khairy P, et al.. Cost-effectiveness of low-dose colchicine after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT). Eur Heart J Qual Care Clin Outcomes. 2021, 7:486-95. 10.1093\/ehjqcco\/qcaa045","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1912388","article-title":"Efficacy and safety of low-dose colchicine after myocardial infarction","volume":"381","author":"Tardif JC","year":"2019","unstructured":"Tardif JC, Kouz S, Waters DD, et al.. Efficacy and safety of low-dose colchicine after myocardial infarction. N Engl J Med. 2019, 381:2497-505. 10.1056\/NEJMoa1912388","journal-title":"N Engl J Med"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCGEN.120.003183","article-title":"Pharmacogenomics of the efficacy and safety of colchicine in COLCOT","volume":"14","author":"Dub\u00e9 MP","year":"2021","unstructured":"Dub\u00e9 MP, Legault MA, Lema\u00e7on A, et al.. Pharmacogenomics of the efficacy and safety of colchicine in COLCOT. Circ Genom Precis Med. 2021, 14:e003183. 10.1161\/CIRCGEN.120.003183","journal-title":"Circ Genom Precis Med"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaa659","article-title":"Time-to-treatment initiation of colchicine and cardiovascular outcomes after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)","volume":"41","author":"Bouabdallaoui N","year":"2020","unstructured":"Bouabdallaoui N, Tardif JC, Waters DD, et al.. Time-to-treatment initiation of colchicine and cardiovascular outcomes after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT). Eur Heart J. 2020, 41:4092-9. 10.1093\/eurheartj\/ehaa659","journal-title":"Eur Heart J"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2405922","article-title":"Colchicine in acute myocardial infarction","volume":"392","author":"Jolly SS","year":"2025","unstructured":"Jolly SS, d'Entremont MA, Lee SF, et al.. Colchicine in acute myocardial infarction. N Engl J Med. 2025, 392:633-42. 10.1056\/NEJMoa2405922","journal-title":"N Engl J Med"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.121.056177","article-title":"Effect of colchicine on myocardial injury in acute myocardial infarction","volume":"144","author":"Mewton N","year":"2021","unstructured":"Mewton N, Roubille F, Bresson D, et al.. Effect of colchicine on myocardial injury in acute myocardial infarction. Circulation. 2021, 144:859-69. 10.1161\/CIRCULATIONAHA.121.056177","journal-title":"Circulation"},{"key":"ref29","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2023-002474","article-title":"Colchicine in acute myocardial infarction: Cardiovascular events at 1-year follow up","volume":"11","author":"Bouleti C","year":"2024","unstructured":"Bouleti C, Viscogliosi S, Bresson D, et al.. Colchicine in acute myocardial infarction: Cardiovascular events at 1-year follow up. Open heart. 2024, 11:002474.","journal-title":"Open heart"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1007\/s10787-021-00865-0","article-title":"Colchicine effectively attenuates inflammatory biomarker high-sensitivity C-reactive protein (hs-CRP) in patients with non-ST-segment elevation myocardial infarction: A randomised, double-blind, placebo-controlled clinical trial","volume":"29","author":"Gholoobi A","year":"2021","unstructured":"Gholoobi A, Askari VR, Naghedinia H, Ahmadi M, Vakili V, Baradaran Rahimi V. Colchicine effectively attenuates inflammatory biomarker high-sensitivity C-reactive protein (hs-CRP) in patients with non-ST-segment elevation myocardial infarction: A randomised, double-blind, placebo-controlled clinical trial. Inflammopharmacology. 2021, 29:1379-87. 10.1007\/s10787-021-00865-0","journal-title":"Inflammopharmacology"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.115.017611","article-title":"Anti-inflammatory treatment with colchicine in acute myocardial infarction: A pilot study","volume":"132","author":"Deftereos S","year":"2015","unstructured":"Deftereos S, Giannopoulos G, Angelidis C, et al.. Anti-inflammatory treatment with colchicine in acute myocardial infarction: A pilot study. Circulation. 2015, 132:1395-403. 10.1161\/CIRCULATIONAHA.115.017611","journal-title":"Circulation"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2019.06.003","article-title":"The low dose colchicine after myocardial infarction (LoDoCo-MI) study: A pilot randomized placebo controlled trial of colchicine following acute myocardial infarction","volume":"215","author":"Hennessy T","year":"2019","unstructured":"Hennessy T, Soh L, Bowman M, Kurup R, Schultz C, Patel S, Hillis GS. The low dose colchicine after myocardial infarction (LoDoCo-MI) study: A pilot randomized placebo controlled trial of colchicine following acute myocardial infarction. Am Heart J. 2019, 215:62-9. 10.1016\/j.ahj.2019.06.003","journal-title":"Am Heart J"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-021-02393-9","article-title":"Effects of colchicine on major adverse cardiac events in next 6-month period after acute coronary syndrome occurrence; a randomized placebo-control trial","volume":"21","author":"Akrami M","year":"2021","unstructured":"Akrami M, Izadpanah P, Bazrafshan M, Hatamipour U, Nouraein N, Drissi HB, Manafi A. Effects of colchicine on major adverse cardiac events in next 6-month period after acute coronary syndrome occurrence; a randomized placebo-control trial. BMC Cardiovasc Disord. 2021, 21:583. 10.1186\/s12872-021-02393-9","journal-title":"BMC Cardiovasc Disord"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.acvd.2016.10.004","article-title":"COLIN trial: Value of colchicine in the treatment of patients with acute myocardial infarction and inflammatory response","volume":"110","author":"Akodad M","year":"2017","unstructured":"Akodad M, Lattuca B, Nagot N, et al.. COLIN trial: Value of colchicine in the treatment of patients with acute myocardial infarction and inflammatory response. Arch Cardiovasc Dis. 2017, 110:395-402. 10.1016\/j.acvd.2016.10.004","journal-title":"Arch Cardiovasc Dis"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1093\/ehjacc\/zuae135","article-title":"Efficacy and safety of colchicine and spironolactone after myocardial infarction: The CLEAR-SYNERGY trial in perspective","volume":"13","author":"Tardif JC","year":"2024","unstructured":"Tardif JC, Kouz S. Efficacy and safety of colchicine and spironolactone after myocardial infarction: The CLEAR-SYNERGY trial in perspective. Eur Heart J Acute Cardiovasc Care. 2024, 13:843-4. 10.1093\/ehjacc\/zuae135","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpcardiol.2024.102878","article-title":"The effect of colchicine on myocardial infarction: An updated systematic review and meta-analysis of randomized controlled trials","volume":"50","author":"Younas A","year":"2025","unstructured":"Younas A, Awan Z, Khan T, et al.. The effect of colchicine on myocardial infarction: An updated systematic review and meta-analysis of randomized controlled trials. Curr Probl Cardiol. 2025, 50:102878. 10.1016\/j.cpcardiol.2024.102878","journal-title":"Curr Probl Cardiol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab115","article-title":"Efficacy and safety of low-dose colchicine in patients with coronary disease: A systematic review and meta-analysis of randomized trials","volume":"42","author":"Fiolet AT","year":"2021","unstructured":"Fiolet AT, Opstal TS, Mosterd A, et al.. Efficacy and safety of low-dose colchicine in patients with coronary disease: A systematic review and meta-analysis of randomized trials. Eur Heart J. 2021, 42:2765-75. 10.1093\/eurheartj\/ehab115","journal-title":"Eur Heart J"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.676771","article-title":"Efficacy and safety of colchicine in post-acute myocardial infarction patients: A systematic review and meta-analysis of randomized controlled trials","volume":"8","author":"Diaz-Arocutipa C","year":"2021","unstructured":"Diaz-Arocutipa C, Benites-Meza JK, Chambergo-Michilot D, et al.. Efficacy and safety of colchicine in post-acute myocardial infarction patients: A systematic review and meta-analysis of randomized controlled trials. Front Cardiovasc Med. 2021, 8:676771. 10.3389\/fcvm.2021.676771","journal-title":"Front Cardiovasc Med"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1007\/s40292-021-00460-y","article-title":"Effects of colchicine on cardiovascular outcomes in patients with coronary artery disease: A systematic review and one-stage and two-stage meta-analysis of randomized-controlled trials","volume":"28","author":"Teo YN","year":"2021","unstructured":"Teo YN, Teo YH, Syn NL, et al.. Effects of colchicine on cardiovascular outcomes in patients with coronary artery disease: A systematic review and one-stage and two-stage meta-analysis of randomized-controlled trials. High Blood Press Cardiovasc Prev. 2021, 28:343-54. 10.1007\/s40292-021-00460-y","journal-title":"High Blood Press Cardiovasc Prev"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaf174","article-title":"Long-term trials of colchicine for secondary prevention of vascular events: A meta-analysis","volume":"46","author":"Samuel M","year":"2025","unstructured":"Samuel M, Berry C, Dub\u00e9 MP, et al.. Long-term trials of colchicine for secondary prevention of vascular events: A meta-analysis. Eur Heart J. 2025, 46:2552-63. 10.1093\/eurheartj\/ehaf174","journal-title":"Eur Heart J"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2023.1194605","article-title":"Early long-term low-dosage colchicine and major adverse cardiovascular events in patients with acute myocardial infarction: A systematic review and meta-analysis","volume":"10","author":"Zhou Y","year":"2023","unstructured":"Zhou Y, Liu Y, Zeng R, Qiu W, Zhao Y, Zhou Y. Early long-term low-dosage colchicine and major adverse cardiovascular events in patients with acute myocardial infarction: A systematic review and meta-analysis. Front Cardiovasc Med. 2023, 10:1194605. 10.3389\/fcvm.2023.1194605","journal-title":"Front Cardiovasc Med"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1097\/FJC.0000000000001200","article-title":"Colchicine for patients with coronary artery disease: A systematic review and meta-analysis","volume":"79","author":"Shrestha DB","year":"2022","unstructured":"Shrestha DB, Budhathoki P, Sedhai Y, et al.. Colchicine for patients with coronary artery disease: A systematic review and meta-analysis. J Cardiovasc Pharmacol. 2022, 79:420-30. 10.1097\/FJC.0000000000001200","journal-title":"J Cardiovasc Pharmacol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/423602-low-dose-colchicine-in-patients-with-type-2-diabetes-with-recent-myocardial-infarction-in-the-colchicine-cardiovascular-outcome-trial-colcot-a-systematic-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T05:16:14Z","timestamp":1761801374000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/423602-low-dose-colchicine-in-patients-with-type-2-diabetes-with-recent-myocardial-infarction-in-the-colchicine-cardiovascular-outcome-trial-colcot-a-systematic-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,29]]},"references-count":42,"URL":"https:\/\/doi.org\/10.7759\/cureus.95715","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,29]]}}}